SCHEMBL8053273

SCHEMBL8053273

C=CC(c1ccc(Cl)c(Cl)c1)C(C)NC

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
SLC6A2 P23975 10/20 0.37
SLC6A4 P31645 10/20 0.37
SLC6A3 Q01959 10/20 0.37
KCNH2 Q12809 6/20 0.37
CYP2D6 P10635 6/20 0.37
CYP3A4 P08684 4/20 0.37
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8053274 1.00 ALDH1A1 (0.40) ALDH1A1LMNAHTTSMN1; SMN2SLC6A2
SCHEMBL8105513 0.78 SLC6A2 (0.43) ALDH1A1LMNAHTTSMN1; SMN2SLC6A2
SCHEMBL13267449 0.74 ALDH1A1 (0.54) ALDH1A1LMNAHTTSMN1; SMN2SLC6A2
SCHEMBL178624 0.74 ALDH1A1 (0.54) ALDH1A1LMNAHTTSMN1; SMN2SLC6A2
SCHEMBL16961922 0.71 AHR (0.44) ALDH1A1LMNAHTTSMN1; SMN2SLC6A2
SCHEMBL2951028 0.69 AHR (0.46) ALDH1A1LMNAHTTSMN1; SMN2SLC6A2
SCHEMBL28125733 0.69 AHR (0.46) ALDH1A1LMNAHTTSMN1; SMN2SLC6A2
SCHEMBL9673577 0.68 AHR (0.41) ALDH1A1LMNAHTTSMN1; SMN2SLC6A2
SCHEMBL9618278 0.68 AHR (0.41) SLC6A2SLC6A4SLC6A3KCNH2CYP2D6
SCHEMBL254524 0.68 AHR (0.50) ALDH1A1LMNAHTTSMN1; SMN2SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6013652-A ANTIINFLAMMATORY AGENTS; ANALGESICS; ANTIHISTAMINES MERCK & CO., INC. (US) 2000-01-11 US disclosed
US-6013644-A AIDS THERAPY MERCK & CO., INC. (US) 2000-01-11 US disclosed
US-5962462-A COMPOUNDS WHICH INHIBIT THE ENTRY OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) INTO TARGET CELLS; DELAYING THE ONSET OF ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS). MERCK & CO., INC. (US) 1999-10-05 US disclosed
US-5869496-A TREATING ASTHMA, EMESIS MERCK & CO., INC. (US) 1999-02-09 US disclosed
EP-0681571-B1 SPIRO-SUBSTITUTED AZACYCLES AS TACHYKININ RECEPTOR ANTAGONISTS MERCK & CO INC (US) 1998-07-29 EP disclosed
WO-1998025604-A1 SPIRO-SUBSTITUTED AZACYCLES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 1998-06-18 WO disclosed
WO-1998025617-A1 SUBSTITUTED ARYL PIPERAZINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 1998-06-18 WO disclosed
WO-1998025605-A1 SPIRO-SUBSTITUTED AZACYCLES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 1998-06-18 WO disclosed
EP-0783498-A4 SUBSTITUTED ARYL PIPERAZINES AS NEUROKININ ANTAGONISTS MERCK & CO INC (US) 1998-04-15 EP disclosed
EP-0783498-A1 SUBSTITUTED ARYL PIPERAZINES AS NEUROKININ ANTAGONISTS MERCK & CO. INC. (US) 1997-07-16 EP disclosed
US-5607936-A USEFUL IN TREATMENT OF RESPIRATORY DISEASES MERCK & CO., INC. (US) 1997-03-04 US disclosed
WO-1996010568-A1 SUBSTITUTED ARYL PIPERAZINES AS NEUROKININ ANTAGONISTS MERCK & CO., INC. (US) 1996-04-11 WO disclosed
EP-0702681-A1 SPIRO-SUBSTITUTED AZACYCLES AS NEUROKININ ANTAGONISTS MERCK & CO. INC. (US) 1996-03-27 EP disclosed
EP-0681571-A1 SPIRO-SUBSTITUTED AZACYCLES AS TACHYKININ RECEPTOR ANTAGONISTS MERCK & CO. INC. (US) 1995-11-15 EP disclosed
WO-1994029309-A1 SPIRO-SUBSTITUTED AZACYCLES AS NEUROKININ ANTAGONISTS MERCK & CO., INC. (US) 1994-12-22 WO disclosed
WO-1994017045-A1 SPIRO-SUBSTITUTED AZACYCLES AS TACHYKININ RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1994-08-04 WO disclosed